The first-in-human Phase 1 clinical trial of the drug candidate HOPO-101, also referred to as HOPO 14-1, is now enrolling healthy participants. Questions about recruitment can be directed to clinical-trials@sri.com and full information, including eligibility requirements, can be found on ClinicalTrials.gov
